secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLIGENIX, INC. (SNGX)
CIK:        0000812796
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001558370-23-019993
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soligenix receives Nasdaq delisting notice; common stock may be suspended
-------------------------------------------------------------------------

- Nasdaq notified Soligenix on Dec 21, 2023, of failure to meet $1.00 minimum bid price rule.
- Company ineligible for second 180-day cure period due to stockholders' equity of $4.22M (below $5M minimum).
- Intends to request a hearing by Dec 28, 2023, to stay suspension pending panel decision.
- Hearing expected within 45 days; company will present plan to regain compliance.
- No immediate impact on listing; shares continue trading on Nasdaq under symbol SNGX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/812796/000155837023019993/0001558370-23-019993-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/812796/000155837023019993/sngx-20231221x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019993

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer